Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
457.40
-1.00 (-0.22%)
Jul 24, 2026, 5:29 PM CET
STO:SOBI Market Cap
STO:SOBI has a market cap or net worth of 158.85 billion as of July 24, 2026. Its market cap has increased by 65.65% in one year.
Market Cap
158.85B
Enterprise Value
175.36B
Revenue
30.62B
Ranking
n/a
PE Ratio
115.63
Stock Price
457.40
ChartMarket Cap Chart
Since September 15, 2006, STO:SOBI's market cap has increased from 4.83B to 158.85B, an increase of 3,189.99%. That is a compound annual growth rate of 19.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 158.85B | 38.49% |
| Dec 30, 2025 | 114.70B | 4.06% |
| Dec 30, 2024 | 110.22B | 20.19% |
| Dec 29, 2023 | 91.70B | 41.80% |
| Dec 30, 2022 | 64.67B | 16.86% |
| Dec 30, 2021 | 55.34B | 12.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.69B |
| Cereno Scientific AB | 1.54B |
| Nanexa AB | 678.17M |
| Dicot Pharma AB | 622.98M |
| EQL Pharma AB | 608.31M |
| Cinclus Pharma Holding AB | 555.66M |
| Orexo AB | 532.21M |
| Enzymatica AB | 456.34M |